Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $278.06 -1.28%
Revenue Growth %: -4.2%
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -4.2%
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.34, $0.25 better than the analyst estimate of $2.09. Revenue for the quarter came in at $984.2 million versus the consensus estimate of $941.47 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.30-$9.80, versus the consensus of $9.31.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Ximen Mining launches $350,000 bridge placement for Kenville mine
- Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
